Hepatocyte-Targeted siTAZ Therapy Lowers Liver Fibrosis in NASH Diet-Fed Chimeric Mice with Hepatocyte-Humanized Livers
X. Wang, M. P. Moore, H. Shi, Y. Miyata, S. K. Donnelly, D. R. Radiloff, I. Tabas
bioRxiv · Oct 27, 2023Pharmacology & Toxicology
Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
5 papers
Recent·Most cited
X. Wang, M. P. Moore, H. Shi, Y. Miyata, S. K. Donnelly, D. R. Radiloff, I. Tabas
bioRxiv · Oct 27, 2023Pharmacology & Toxicology
K. Mizutani, Y. Yoshida, E. Nakanishi, Y. Miyata, S. Tokumoto, H. Fuse, O. Gusev, S. Kikuta, T. Kikawada
This paper identifies STRT1, a sodium-dependent trehalose transporter in Pv11 cells, which is essential for recovery from anhydrobiosis by regulating intracellular osmolality during rehydration.
bioRxiv · Sep 29, 2023Biochemistry
S. Tokumoto, Y. Miyata, K. Usui, R. Deviatiiarov, T. Ohkawa, S. Kondratieva, E. Shagimardanova, O. Gusev, R. Cornette, M. Itoh, Y. Hayashizaki, T. Kikawada
The paper develops a Tet-On inducible expression system for the desiccation-tolerant Pv11 cell line, demonstrating successful expression of reporter genes and a complex enzyme.
bioRxiv · May 29, 2020Bioengineering
M. Dent, K. Hamorsky, T. Vausselin, J. D. Dubuisson, Y. Miyata, Y. Morikawa, N. Matoba
This paper evaluates the safety and efficacy of Avaren-Fc, a HCV-targeting lectibody, in a human liver chimeric mouse model, showing it prevents HCV infection without toxicity.
bioRxiv · Apr 22, 2020Pharmacology & Toxicology